Zealand Pharma A/s

Wayne Shaun Russell

Ditte Riber

Rasmus Just

Kirsten Lindegaard Bovbjerg

GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Glucagon-like-peptide-2 (GLP-2) analogues

GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis, treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Growing community of inventors

Kävlinge, Sweden

Wayne Shaun Russell